Abbott buys Topera, enters new heart-treatment market

SHARE Abbott buys Topera, enters new heart-treatment market

Abbott Laboratories is moving into a new area for heart treatments with the purchase of medical device company Topera Inc.

The North Chicago company announced Wednesday it will pay $250 million for Menlo Park, California-based Topera, which makes catheters used in treating people with atrial fibrillation, a common heart rhythm disorder.

Continue reading at Newsfeed.

The Latest
Morgan Park High School trumpeters riff on the most popular brass instrument.
About 60% of people are interested in exploring green funeral options, more than ever before.
The rising tide of antisemitic incidents in Chicago’s neighborhoods has shaken our community to its core. The best response is to strengthen our Jewish pride and practice, an approach that mirrors the essence of Passover.
The officer had his vehicle stolen after the attack, Supt. Larry Snelling told reporters. The shooter or shooters remained at large.
Not that many decades ago, it was common for a midwife and close female family members to come together in the home to provide support for Black women during childbirth. We need that same partnership today, the director of West Side United writes.